PTSD Therapy for Healthcare Workers' Stress
Trial Summary
The trial does not specify if you need to stop taking your current medications, but it requires that your medication has been stable for at least 4 weeks before joining. It's best to discuss this with the trial team or your doctor.
Prolonged Exposure for Primary Care (PE-PC) has been shown to effectively reduce PTSD and depression symptoms in veterans, with medium-to-large reductions in PTSD symptoms and small-to-medium reductions in depression symptoms. It is a brief version of Prolonged Exposure therapy, adapted for primary care settings, and has been found feasible and acceptable in low-resource settings, indicating its potential effectiveness for healthcare workers' stress.
12345Prolonged exposure therapy has been extensively researched and is considered a safe and effective treatment for PTSD, with clinical guidelines supporting its use. It has been shown to reduce symptoms of PTSD and related issues like depression and anger in various populations, including veterans and military personnel.
12467Prolonged Exposure for Primary Care (PE-PC) is a unique treatment for PTSD because it is a brief version of the standard Prolonged Exposure therapy, designed specifically for primary care settings. It involves four 30-minute sessions focusing on confronting trauma memories and related avoidance, making it more accessible and feasible for healthcare workers who may not have time for longer therapy sessions.
12345Eligibility Criteria
This trial is for healthcare workers with PTSD symptoms post-COVID-19, who have a PCL-5 score ≥33 and stable psychotropic medication use. Participants must work in a healthcare system with an EAP. Those with active psychosis, high suicide risk, current trauma-focused treatment, non-English speakers, severe cognitive impairment or needing detoxification cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Prolonged Exposure for Primary Care (PE-PC) or EAP Treatment as Usual (TAU) to address PTSD symptoms
Follow-up
Participants are monitored for changes in PTSD symptoms, burnout, job performance, depressive symptoms, and patient satisfaction
Participant Groups
Prolonged Exposure for Primary Care (PE-PC) is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Posttraumatic Stress Disorder (PTSD)